Source: European Medicines Agency (EU) Revision Year: 2021 Publisher: Bayer AG, 51368 Leverkusen, Germany
Verquvo 2.5 mg film-coated tablets.
Verquvo 5 mg film-coated tablets.
Verquvo 10 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet (tablet). Verquvo 2.5 mg film-coated tablets: Round, biconvex, white film-coated tablet with a diameter of 7 mm, marked with “2.5” on one side and “VC” on the other side. Verquvo 5 mg film-coated tablets: Round, biconvex, brown-red film-coated tablet with a diameter of 7 mm, marked with “5” on one side and “VC” on the other side. Verquvo 10 mg film-coated tablets: Round, biconvex, yellow-orange film-coated tablet with a diameter of 9 mm, marked with “10” on one side and “VC” on the other side. |
Each film-coated tablet contains 2.5 mg vericiguat.
Excipient with known effect: Each film-coated tablet contains 58.14 mg lactose (as monohydrate), see section 4.4.
Each film-coated tablet contains 5 mg vericiguat.
Excipient with known effect: Each film-coated tablet contains 55.59 mg lactose (as monohydrate), see section 4.4.
Each film-coated tablet contains 10 mg vericiguat.
Excipient with known effect: Each film-coated tablet contains 111.15 mg lactose (as monohydrate), see section 4.4.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Vericiguat |
Vericiguat is a stimulator of soluble guanylate cyclase (sGC). Heart failure is associated with impaired synthesis of nitric oxide (NO) and decreased activity of its receptor, sGC. The pharmacodynamic effects of vericiguat are consistent with the mode of action of a sGC stimulator resulting in smooth muscle relaxation and vasodilation. |
| List of Excipients |
|---|
|
Tablet core: Microcrystalline cellulose Film-coat: Hypromellose 2910 |
PVC/PVDC/Aluminium foil blisters in cartons of 14, 28 or 98 film-coated tablets or perforated unit dose blisters in cartons of 10 × 1 or 100 × 1 film-coated tablets.
PP/Aluminium foil blisters in cartons of 14, 28 or 98 film-coated tablets or perforated unit dose blisters in cartons of 10 × 1 or 100 × 1 film-coated tablets.
HDPE bottles with a PP screw cap containing 100 film-coated tablets.
Not all pack sizes may be marketed.
Bayer AG, 51368 Leverkusen, Germany
Verquvo 2.5 mg film-coated tablets: EU/1/21/1561/001–011
Verquvo 5 mg film-coated tablets: EU/1/21/1561/012–022
Verquvo 10 mg film-coated tablets: EU/1/21/1561/023–033
| Drug | Countries | |
|---|---|---|
| VERQUVO | Austria, Ecuador, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
